申请人:Wageningen Universiteit
公开号:EP3827825A1
公开(公告)日:2021-06-02
The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof as an antibacterial or antibiotic
against Staphylococcus, Escherichia, Streptococcus, Klebsiella, Mycobacterium, Pseudomonas, Clostridium, Acinetobacter, Enterococcus, Pasteurella Bacillus anthracis. Listeria monocytogenes, Corynebacterium diphtheriae, Salmonella, Shigella, Moraxella, Helicobacter, Legionella, Vibrio, Rickettsia, Neisseria, Actinobacter, is disclosed.
式 (I) 化合物或其药学上可接受的盐或溶液作为抗菌剂或抗生素的用途
抗葡萄球菌、埃希菌、链球菌、克雷伯氏菌、分枝杆菌、假单胞菌、梭菌、醋纤杆菌、肠球菌、巴斯德氏炭疽杆菌单核细胞增生李斯特菌、白喉杆菌、沙门氏菌、志贺氏菌、莫拉氏菌、螺旋杆菌、军团菌、弧菌、立克次体、奈瑟氏菌、放线菌等均已公开。